These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28855992)

  • 1. Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer.
    Kumamoto K; Ishida H; Kuwabara K; Amano K; Chika N; Okada N; Ohsawa T; Kumagai Y; Ishibashi K
    Mol Clin Oncol; 2017 Oct; 7(4):595-600. PubMed ID: 28855992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
    Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
    Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice.
    Gohara S; Yoshida R; Kawahara K; Sakata J; Arita H; Nakashima H; Kawaguchi S; Nagao Y; Yamana K; Nagata M; Hirosue A; Hiraki A; Nakayama H
    Mol Clin Oncol; 2021 Oct; 15(4):209. PubMed ID: 34462664
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
    Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
    J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of serum anti-p53 antibody measurement for colorectal cancer].
    Kuwabara K; Kumamoto K; Ishibashi K; Ohsawa T; Kumagai Y; Baba H; Tsuji Y; Haga N; Ishida H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2167-9. PubMed ID: 23268012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients.
    Yamaguchi T; Takii Y; Maruyama S
    Surg Today; 2014 Aug; 44(8):1529-35. PubMed ID: 23975589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
    Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
    Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meprin α combined with CEA and CA19-9 improves prognostic prediction for surgically treated colorectal cancer patients.
    Hou H; Gou X; Bu J; Su Y; Wei X; Wang X; Hou B
    Int J Clin Exp Pathol; 2017; 10(10):10441-10450. PubMed ID: 31966381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
    Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
    J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
    Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
    Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M; Maruszyński M; Piechota W
    Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.